CERVARIX human papillomavirus vaccine types 16 and 18 [recombinant, AS04 adjuvanted] suspension for injection pre-filled syringe (HPV Type 16 L1 Protein)
Webinar: nieuw HPV-screeningsbeleid en -vaccinatie - 19 november 2024 - Medi-Sfeer
Conspiracy theorists are turning their attention back to HPV vaccines
We are living in a vaccine-hesitant moment, with conspiracy theories thriving on social media. We need to push back, says Simon Williams
Too Few Girls Get HPV Vaccine Against Cancer: CDC
Title: Too Few Girls Get HPV Vaccine Against Cancer: CDC
Category: Health News
Created: 8/30/2012 4:05:00 PM
Last Editorial Review: 8/31/2012 12:00:00 AM
HPV Vaccination Rates Among Teens Still Lagging: CDC
Title: HPV Vaccination Rates Among Teens Still Lagging: CDC
Category: Health News
Created: 8/29/2013 4:36:00 PM
Last Editorial Review: 8/30/2013 12:00:00 AM
Health Tip: Getting the HPV Vaccine
Title: Health Tip: Getting the HPV Vaccine
Category: Health News
Created: 8/30/2017 12:00:00 AM
Last Editorial Review: 8/30/2017 12:00:00 AM
HPV Vaccine Doesn't Put Girls' Fertility at Risk: Study
Title: HPV Vaccine Doesn't Put Girls' Fertility at Risk: Study
Category: Health News
Created: 8/24/2018 12:00:00 AM
Last Editorial Review: 8/27/2018 12:00:00 AM
U.S. HPV Vaccination Rates Rising, Even Among Boys
Title: U.S. HPV Vaccination Rates Rising, Even Among Boys
Category: Health News
Created: 6/22/2022 12:00:00 AM
Last Editorial Review: 6/23/2022 12:00:00 AM
Vaccines Have Slashed Rates of HPV Infection in Young American Women
Title: Vaccines Have Slashed Rates of HPV Infection in Young American Women
Category: Health News
Created: 8/22/2022 12:00:00 AM
Last Editorial Review: 8/23/2022 12:00:00 AM
Conspiracy theorists are turning their attention back to HPV vaccines
We are living in a vaccine-hesitant moment, with conspiracy theories thriving on social media. We need to push back, says Simon Williams
One Shot for All: Welcoming a One-Dose Gender-Neutral HPV Vaccination
Canadian vaccination programs could eliminate medlinkcervical cancer/medlink by switching to a 1-dose gender-neutral medlinkhuman papillomavirus/medlink
One-Third of Men Worldwide Infected With Genital HPV
Twenty percent of individuals carry one or more high-risk or oncogenic types of human papillomavirus (HPV), stated a new study published in iThe Lancet Global Health.
Merck Announces New FDA-Approved Guidelines for HPV Vaccine
The U.S. Food and Drug Administration (USFDA) has released a new set of guidelines for the use of already approved Recombinant Human Papillomavirus 9-valent Vaccine in males.
A single-injection vaccine providing protection against two HPV types
DOI: 10.1039/D4TB00606B, Paper
A bivalent single-injection HPV vaccine was designed using a new pulsatile release drug carrier.
The content of this RSS Feed (c) The Royal Society of Chemistry
HPV and Pap Testing
A fact sheet that describes cervical cancer screening, which includes the Pap test and HPV testing. The fact sheet includes information about cervical cancer screening guidelines.
More teen girls need HPV shot, says CDC
Despite the HPV vaccine being effective at preventing infections and cancers down the line, just one-third of teen girls complete the injection series.
70 percent of Americans infected with HPV
More than two-thirds of healthy Americans have a human papillomavirus (HPV) infection on some part of their body
Not enough teens get HPV vaccine, says CDC
The number of teenage girls and boys in the United States who have received the vaccine remains "unacceptably low" says the CDC.
Effect of HPV Vaccine on Rate of Cancer-Causing Infections
HPV vaccine programs designed to reduce this significant public health threat, and recent research indicates that they're working. The American Dental Society supports the use of this vaccine
JADA’s new CSA Corner highlights ACE Panel survey results on HPV vaccine
Dentists’ comfort levels and perceived roles in discussing and administering the human papillomavirus vaccine appear to vary, according to the results of an American Dental Association Clinical Evaluators Panel survey published in The Journal of the American Dental Association.
“Mandate-Schmandate,” Rick Perry and the HPV vaccine – by Richard Thaler
Nudge blog note: Last night’s Republican debate prompted Richard Thaler to weigh in on Rick Perry’s handling of an HPV vaccine executive order, but not the policy itself. Also, Thaler recently started tweeting. Follow him. By Richard Thaler In the Republican Presidential debate last night at the Reagan library a question emerged about Rick Perry’s [...]
Effectiveness of Decision Support for Families, Clinicians, or Both on HPV Vaccine Receipt
Despite proven health benefits, human papillomavirus (HPV) vaccination rates are among the lowest of all routine immunizations. No previous large-scale trial has compared the benefit of automated decision support directed at clinicians, families, or both in any context.
We found that a clinician-focused intervention was most effective for initiating the HPV vaccine series, whereas a family-focused intervention supported completion. Decision support directed at both clinicians and families most effectively promotes HPV vaccine series receipt. (Read the full article)
Risk Perceptions and Subsequent Sexual Behaviors After HPV Vaccination in Adolescents
Concerns have been raised that human papillomavirus (HPV) vaccination could lead to riskier behaviors in vaccinated adolescents, but it is unknown whether changes in risk perceptions after vaccination lead to riskier sexual behaviors.
Risk perceptions following HPV vaccination were not associated with subsequent riskier sexual behaviors in sexually experienced and inexperienced young women. These data contribute to the growing evidence that HPV vaccination does not lead to changes in sexual behaviors among adolescents. (Read the full article)
Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study
Rates of human papillomavirus (HPV) vaccination lag behind other adolescent vaccines. Research indicates that provider recommendation is the key to improving HPV vaccination rates and that most adolescents who are unvaccinated received other vaccines, indicating missed opportunities for HPV vaccination.
This study explores in-depth the content of provider–patient conversations that either create or prevent opportunities for HPV vaccination. Effective and ineffective conversations are presented with the goal of providing practical tools to improve communication regarding HPV vaccines. (Read the full article)
Parent and Adolescent Knowledge of HPV and Subsequent Vaccination
Vaccinating youth is among the nation’s highest health care priorities. Despite proven health benefits, human papillomavirus vaccination rates remain low.
This is the first known study to test whether vaccination of high-risk adolescents is related to their or their parents’ previous knowledge levels. In the results presented, neither parental nor adolescent knowledge is related to subsequent adolescent vaccination. (Read the full article)
Immunogenicity and Safety of a 9-Valent HPV Vaccine
Prophylactic vaccination of young women 16 to 26 years of age with the 9-valent human papillomavirus (HPV)–like particle (9vHPV) vaccine prevents infection and disease with vaccine HPV types.
These data support bridging the efficacy findings with 9vHPV vaccine in young women 16 to 26 years of age to girls and boys 9 to 15 years of age and implementation of gender-neutral HPV vaccination programs in preadolescents and adolescents. (Read the full article)
Promoting HPV Vaccination in Safety-Net Clinics: A Randomized Trial
Previous studies have evaluated separately the effects of brief education and reminder/recall intervention strategies to increase human papillomavirus vaccine coverage. None have examined if intervention effects varied by race/ethnicity.
When compared with a general adolescent vaccine brochure, human papillomavirus vaccine-specific educational materials increased 1-dose coverage among Hispanic but not black individuals. Recalls for doses 2 and 3 were effective in increasing 3-dose coverage for both racial/ethnic groups. (Read the full article)
HPV Vaccination Coverage of Male Adolescents in the United States
HPV is the most common sexually transmitted infection in the United States. More than 50% of sexually active men and women will acquire HPV infection in their lifetime. In 2011, HPV was recommended for routine use among male adolescents.
HPV Test Beats Pap Smear for Cancer Screening
Title: HPV Test Beats Pap Smear for Cancer Screening
Category: Health News
Created: 4/28/2010 12:10:00 PM
Last Editorial Review: 4/29/2010 12:00:00 AM
HPV-Linked Oral Cancers May Not Be 'Contagious'
Title: HPV-Linked Oral Cancers May Not Be 'Contagious'
Category: Health News
Created: 4/29/2014 2:36:00 PM
Last Editorial Review: 4/30/2014 12:00:00 AM
HPV Vaccine Produces Early Benefits for Teen Girls: Study
Title: HPV Vaccine Produces Early Benefits for Teen Girls: Study
Category: Health News
Created: 4/27/2015 12:00:00 AM
Last Editorial Review: 4/27/2015 12:00:00 AM
One Dose of HPV Vaccine May Protect Against Cervical Cancer
Title: One Dose of HPV Vaccine May Protect Against Cervical Cancer
Category: Health News
Created: 2/10/2020 12:00:00 AM
Last Editorial Review: 2/10/2020 12:00:00 AM
Effect of State Immunization Information System Centralized Reminder and Recall on HPV Vaccination Rates
Although autodialer centralized reminder and recall (C-R/R) from state immunization information systems (IISs) has been shown to raise childhood vaccination rates, its impact on human papillomavirus (HPV) vaccination rates is unclear.
In a 4-arm pragmatic randomized controlled trial across 2 states, we randomly selected practices representative of the specialty (pediatrics, family medicine, and health center) where children received care. Within each practice, patients 11 to 17.9 years old who had not completed their HPV vaccine series (NY: N = 30 616 in 123 practices; CO: N = 31 502 in 80 practices) were randomly assigned to receive 0, 1, 2, or 3 IIS C-R/R autodialer messages per vaccine dose. We assessed HPV vaccine receipt via the IIS, calculated intervention costs, and compared HPV vaccine series initiation and completion rates across study arms.
In New York, HPV vaccine initiation rates ranged from 37.0% to 37.4%, and completion rates were between 29.1% and 30.1%, with no significant differences across study arms. In Colorado, HPV vaccine initiation rates ranged from 31.2% to 33.5% and were slightly higher for 1 reminder compared with none, but vaccine completion rates, ranging from 27.0% to 27.8%, were similar. On adjusted analyses in Colorado, vaccine initiation rates were slightly higher for 1 and 3 C-R/R messages (adjusted risk ratios 1.07 and 1.04, respectively); completion rates were slightly higher for 1 and 3 C-R/R messages (adjusted risk ratios 1.02 and 1.03, respectively).
IIS-based C-R/R for HPV vaccination did not improve HPV vaccination rates in New York and increased vaccination rates slightly in Colorado.
Strong HPV Vaccine Response Predicts Better Survival with Chemotherapy [Clinical Trials]
Patients with HPV16+ cervical cancer and high T-cell responses to an HPV16 vaccine survived longer.
Individual HPV Types Linked to HIV Infection Discovered
For the first time scientists have discovered 37 individual types of the human papillomavirus, or HPV, that are specifically associated with human immunodeficiency virus (HIV) infection.
HPV Vaccination: Safety Concerns Top the List
Concerns that the HPV vaccination would encourage or support youth sexual activity have led to only a minority of parents to immunize their children against
Culturally Tailored Intervention Increases HPV Vaccination of Asian-American Adolescents
A culturally tailored multilevel strategy designed by scientists significantly increased human papillomavirus (HPV) vaccine uptake among low-income, mostly
HPV is Not Transmittable Through Hands
Having HPV in your hand does not increase the risk of transmitting HPV infection to a sexual partner, finds a study published in iThe Lancet Infectious Diseases/i.
Vaccination Programs Curb HPV Infections (and) Precancerous Cervical Lesions
Human papilloma virus (HPV) vaccination programs found to decrease the number of infections and precancerous cervical lesions caused by the virus significantly,
Oral HPV DNA Detection in Teen, Young Adult Females
Human papilloma virus DNA was detected in 6.2% of 1,259 participants (ages 13 to 21) at baseline but oral HPV detection became less likely with time since becoming sexually active, said researchers.
What Motivates the Parents to Get Their Children HPV Vaccinated?
Cancer prevention is believed to be the most important motivating factor for the parents to get their children HPV vaccinated, finds a new study. The
Bill Gates had to explain difference between HPV and HIV to Trump
The American president was considering a commission to look into the ill effects of vaccines, and was bewildered about HIV and HPV, so he asked the Microsoft founder to explain the differences.
ASK DR ELLIE: She was given the jab - so why did my daughter get HPV?
DR ELLIE CANNON: In England, cervical screening aims to detect high-risk HPV. For most people, HPV is cleared within two years, so it is possible that next time, HPV won't be detected.
HPV and Pap Testing
A fact sheet that describes cervical cancer screening, which includes the Pap test and HPV testing. The fact sheet includes information about cervical cancer screening guidelines.
Ptaquiloside from bracken (Pteridium spp.) promotes oral carcinogenesis initiated by HPV16 in transgenic mice
DOI: 10.1039/D0FO00207K, Paper
Bracken (Pteridium spp.) is a common weed that is consumed as food especially in Asia, and is suspected of promoting carcinogenesis induced by papillomaviruses in the digestive and urinary systems.
The content of this RSS Feed (c) The Royal Society of Chemistry